Caitong International Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.1K Buy
+352
New +$5.02K ﹤0.01% 1311
2025
Q4
Sell
-10
Closed -$124 1949
2025
Q3
$124 Sell
10
-179
-95% -$2.1K ﹤0.01% 1726
2025
Q2
$2.18K Buy
189
+150
+385% +$1.78K ﹤0.01% 1360
2025
Q1
$585 Buy
+39
New +$653 ﹤0.01% 1728

Other funds holding CLB

Caitong International Asset Management's CLB Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Core Laboratories (CLB) in Q2 2026: 352 shares worth $4.1K. The stake represents ﹤0.01% of the portfolio and ranks #1311 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in CLB as recently as Q3 2025.

Caitong International Asset Management first reported a position in CLB in Q1 2025 and has held it in 4 quarters since. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Caitong International Asset Management held 352 shares of Core Laboratories worth $4.1K as of Q2 2026.
  • Core Laboratories was a new Caitong International Asset Management position in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1311 holding.
  • Caitong International Asset Management first reported a position in Core Laboratories in Q1 2025 and has held it in 4 quarters since.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.